5α-Reductase inhibitors and risk of high-grade or lethal prostate cancer.

导出 LinkOut

翻译打印收藏纠错

作者： Mark A,Preston ^[1] ; Kathryn M,Wilson ^[2] ; Sarah C,Markt ^[3] ; Rongbin,Ge ^[1] ; Christopher,Morash ^[4] ; Meir J,Stampfer ^[2] ; Massimo,Loda ^[5] ; Edward,Giovannucci ^[6] ; Lorelei A,Mucci ^[2] ; Aria F,Olumi ^[1]

作者单位： Department of Urology, Massachusetts General Hospital, Boston. ^[1] Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts3Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. ^[2] Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts. ^[3] Division of Urology, University of Ottawa, Ottawa, Ontario, Canada. ^[4] Departments of Pathology and Medical Oncology, Dana-Farber Cancer Institute, Brigham and Women's and Hospital, Boston, Massachusetts6Broad Institute of Harvard and MIT, Cambridge, Massachusetts7Division of Cancer Studies, King's College London, London, En. ^[5] Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts3Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts8Department of Nutrition, Harva. ^[6]

主题词 5-α还原酶抑制剂(5-alpha Reductase Inhibitors);成年人(Adult);老年人(Aged);队列研究(Cohort Studies);疾病恶化(Disease Progression);人类(Humans);发病率(Incidence);纵向研究(Longitudinal Studies);男(雄)性(Male);中年人(Middle Aged);比例危险度模型(Proportional Hazards Models);前瞻性研究(Prospective Studies);前列腺增生(Prostatic Hyperplasia);前列腺肿瘤(Prostatic Neoplasms);危险因素(Risk Factors)

DOI 10.1001/jamainternmed.2014.1600

PMID 24887392

发布时间 2021-10-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览12

JAMA internal medicine

2014年174卷8期

1301-7页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

5α-Reductase inhibitors and risk of high-grade or lethal prostate cancer.

JAMA internal medicine

相似文献

JAMA internal medicine

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

5α-Reductase inhibitors and risk of high-grade or lethal prostate cancer.

JAMA internal medicine

相似文献

JAMA internal medicine

相关期刊

检索历史清除